focus -WSS

focus

author：focus 2025-09-27 17:57:29 - browse：9621

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： IVF, abortion rights issues kick off Biden’s State of the Union

WSS

Change Healthcare cyberattack prompts Medicare loan program

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

FDA advisory panel to debate high blood pressure devices

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

People can get long Covid without testing positive for virus: Study

explore

focus

explore

After affirmative action ruling, medical educators look to 'holistic review'

Roche's accidental data boosts hopes for anti

As demand for Covid shots wanes, Moderna seeks its next success

PBMs are inflating the cost of generic drugs. They must be reined in

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Vivek Ramaswamy made waves in the debate, much as in biotech

Apple is now the first public company to be valued at $3 trillion

Roche's accidental data boosts hopes for anti

Activists slam private health insurers over coverage restrictions

Vivek Ramaswamy made waves in the debate, much as in biotech

hotspot

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Just how do doctors, lawmakers, and the public define abortion?

How the first Native Hawaiian psychiatrist helped diversify medicine

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

How the first Native Hawaiian psychiatrist helped diversify medicine

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

entertainment

hotspot

leisure time

entertainment